OMB First to Final Action Recommendation Checklist 11-12-18
7DEOH
% 6,0 DFTXLVLWLRQ SDUDPHWHUV E\ *& 06 IRU WKH SHVWLFLGHV RI LQWHUHVW LQ WKLV VWXG\
Group
Start time, min
Monitored ions, m / z
Dwell time, ms
1 2 3 4 5 6 7 8 9
14.85 16.85 17.97 19.43 20.00 21.77 22.93 24.20 25.87 28.49
306, 264, 335
80 80 80 40 80 80 80 80 40 40
177, 197, 161, 198, 199, 200 173, 255, 240, 166, 238, 138
154, 230, 203, 285, 287, 270, 265, 267, 250
290, 276, 305
246, 318, 176, 353, 355, 351 359, 303, 357, 318, 316, 246 335, 303, 367, 283, 285, 255
237, 272, 307, 247, 328, 408, 148, 206, 325 181, 166, 165, 266, 394, 267, 341, 183, 339
10
LRQL]DWLRQ VRXUFH DQG 0RGHO * ' DXWRVDPSOHU ZLWK D 0DVV +XQWHU GDWD SURFHVVLQJ VRIWZDUH V\VWHP $JLOHQW 7HFKQRORJLHV ( 2 ) Column ²=RUED[ 6% & î PP î ȝP RU equivalent. ( 3 ) 0RELOH SKDVH JUDGLHQW HOXWLRQ SURJUDP DQG ÀRZ UDWH .— See Table 2014.09E . ( 4 ) Column temperature .—40°C.
( 2 2SHUDWLQJ FRQGLWLRQV DUH WKH VDPH DV IRU *& 06 ZLWK WKH H[FHSWLRQ WKDW WKH LRQ PRQLWRULQJ PRGH LV E\ VHOHFWHG UHDFWLRQ monitoring (SRM) and monitoring one precursor ion and two product ion transitions. ( 3 ) The monitored ion transitions and the collision energies for WKH SHVWLFLGHV RI LQWHUHVW LQ WKH VWXG\ DQG KHSWDFKORU HSR[LGH DUH shown in Table 2014.09C . The SRM acquisition parameters for the SUHFXUVRU DQG SURGXFW LRQ WUDQVLWLRQV PRQLWRUHG E\ *& 06 06 DUH shown in Table 2014.09D . (c) LC/MS/MS analysis.— ( 1 ) LC/MS/MS system .—An Agilent 6HULHV +3/& V\VWHP GLUHFWO\ FRXSOHG WR D WULSOH quadrupole mass spectrometer equipped with an electrospray
( 5 ) Injection volume ² ȝ/ ( 6 ) Ionization mode ²(6, ( 7 ) Ion source polarity .—Positive ion. ( 8 ) Nebulizer gas .—Nitrogen gas. ( 9 ) Nebulizer gas pressure .—0.28 Mpa.
7DEOH
& *& 06 06 UHWHQWLRQ WLPHV PRQLWRUHG LRQ WUDQVLWLRQV FROOLVLRQ HQHUJLHV /2'V DQG /24V IRU WKH SHVWLFLGHV
Quantifying precursor/production transition, m / z
Qualifying precursor/production transition, m / z
Retention time, min
Collision energy, V
No.
Pesticide
/24 ȝJ NJ
/2' ȝJ NJ
ISTD Heptachlor-epoxide
22.15 15.41 17.40 17.42 18.91 19.02 19.73 19.83 19.87 20.36 22.79 23.16 23.90 24.70 24.75 27.18 27.37 27.66 28.63 28.73 29.46
353/263 306/264 177/127 200/199 173/145 238/166 230/154 287/272 267/252 290/233 318/248 359/303 318/248 283/96 335/173 237/208 408/59 148/105 181/166 266/218 341/185
353/282 306/206 177/101 183/102 173/109 238/96 230/111 287/242 267/93 290/125 318/246 359/331 318/246 283/255 335/303 237/182 408/363 148/79 181/165 266/246 341/183
17;17 12;15 13;25 10;30 15;25 15;25
1 2 3 4 5 6 7 8 9
7ULÀXUDOLQ 7HÀXWKULQ
4.8 0.8 6.0 1.0 4.0 2.0
2.4 0.4 3.0 0.5 2.0 1.0 8.0 5.0 5.0 3.0 5.0 2.0 1.0 5.0
Pyrimethanil Propyzamide
Pirimicarb
Dimethenamid Fenchlorphos Tolclofos-methyl Pirimiphos-methyl
8;25
15;25 15;25
16.0 10.0 10.0
5;15
10 11 12 13 14 15 16 17 18 19 20
2,4’-DDE
15;15 10;10 25;25 10;10 10;10 25;25
6.0
Bromophos-ethyl
10.0
4,4’-DDE
4.0 2.0
Procymidone Picoxystrobin Quinoxyfen Chlorfenapyr
10.0 80.0
40.0 70.0
15;5
140.0
Benalaxyl Bifenthrin
15;25
2.0
1.0 5.0
10;5
10.0 20.0
'LÀXIHQLFDQ
25;10 15;15
10.0
Bromopropylate
8.0
4.0
© 2015 AOAC INTERNATIONAL
Made with FlippingBook - Online magazine maker